Form 4: Precision BioSciences' Chief Research Officer Acquires Shares in Private Placement

J. Jefferson Smith, Chief Research Officer of Precision BioSciences, acquired 833 shares of common stock through a private placement on May 8, 2024.

Summary

• J. Jefferson Smith, the Chief Research Officer of Precision BioSciences, acquired 833 shares of the company's common stock on May 8, 2024.
• The shares were purchased at a price of $12 per share through a non-brokered private placement.
• Following the transaction, Smith directly owns 68,446 shares of Precision BioSciences' common stock.
• Smith also indirectly owns 7,931 shares through a Charitable Remainder Unitrust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a transaction. The fact that a key executive is participating in a private placement could be seen as slightly positive, but it's not a major event.

Positives

• The purchase of shares by a key executive could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Private placements are a common way for companies to raise capital, and participation by management can be viewed favorably.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.

Key Dates